nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—PTGFR—Small Ligand GPCRs—MTNR1B—metabolic syndrome X	0.0675	0.0861	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Small Ligand GPCRs—MTNR1B—metabolic syndrome X	0.0661	0.0843	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—HSD11B1—metabolic syndrome X	0.0603	0.0769	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—HSD11B1—metabolic syndrome X	0.059	0.0752	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Small Ligand GPCRs—CNR1—metabolic syndrome X	0.0472	0.0602	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Small Ligand GPCRs—CNR1—metabolic syndrome X	0.0462	0.059	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—PLA2G4A—metabolic syndrome X	0.0253	0.0323	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—PLA2G4A—metabolic syndrome X	0.0248	0.0316	CbGpPWpGaD
Carboprost Tromethamine—Respiratory distress—Metformin—metabolic syndrome X	0.0213	0.105	CcSEcCtD
Carboprost Tromethamine—Chest discomfort—Metformin—metabolic syndrome X	0.0153	0.0755	CcSEcCtD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—metabolic syndrome X	0.0143	0.0182	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—metabolic syndrome X	0.014	0.0178	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Other—CNR1—metabolic syndrome X	0.0135	0.0172	CbGpPWpGaD
Carboprost Tromethamine—Tafluprost—PTGS2—metabolic syndrome X	0.0132	1	CrCbGaD
Carboprost Tromethamine—Lightheadedness—Metformin—metabolic syndrome X	0.0121	0.0598	CcSEcCtD
Carboprost Tromethamine—Lethargy—Metformin—metabolic syndrome X	0.01	0.0495	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Metformin—metabolic syndrome X	0.00898	0.0443	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—HTR2C—metabolic syndrome X	0.00845	0.0108	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.00838	0.0107	CbGpPWpGaD
Carboprost Tromethamine—Sweating increased—Metformin—metabolic syndrome X	0.00828	0.0408	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—HTR2C—metabolic syndrome X	0.00827	0.0105	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.0082	0.0105	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—GHRL—metabolic syndrome X	0.00801	0.0102	CbGpPWpGaD
Carboprost Tromethamine—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.0079	0.039	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—GHRL—metabolic syndrome X	0.00784	0.01	CbGpPWpGaD
Carboprost Tromethamine—Drowsiness—Metformin—metabolic syndrome X	0.00758	0.0374	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—metabolic syndrome X	0.00755	0.00963	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—metabolic syndrome X	0.00739	0.00943	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.00718	0.00916	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—metabolic syndrome X	0.00716	0.00913	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.00703	0.00896	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—metabolic syndrome X	0.00701	0.00894	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.00653	0.00833	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.00639	0.00815	CbGpPWpGaD
Carboprost Tromethamine—Flushing—Metformin—metabolic syndrome X	0.00632	0.0311	CcSEcCtD
Carboprost Tromethamine—Chills—Metformin—metabolic syndrome X	0.00611	0.0301	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.00586	0.00748	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.00574	0.00732	CbGpPWpGaD
Carboprost Tromethamine—Muscle spasms—Metformin—metabolic syndrome X	0.0057	0.0281	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00559	0.00713	CbGpPWpGaD
Carboprost Tromethamine—Vision blurred—Metformin—metabolic syndrome X	0.00558	0.0275	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00547	0.00698	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.00547	0.00697	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.00535	0.00683	CbGpPWpGaD
Carboprost Tromethamine—Syncope—Metformin—metabolic syndrome X	0.00531	0.0262	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.0053	0.00676	CbGpPWpGaD
Carboprost Tromethamine—Palpitations—Metformin—metabolic syndrome X	0.00524	0.0258	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Metformin—metabolic syndrome X	0.00521	0.0257	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00519	0.00662	CbGpPWpGaD
Carboprost Tromethamine—Hypertension—Metformin—metabolic syndrome X	0.00511	0.0252	CcSEcCtD
Carboprost Tromethamine—Chest pain—Metformin—metabolic syndrome X	0.00504	0.0249	CcSEcCtD
Carboprost Tromethamine—Myalgia—Metformin—metabolic syndrome X	0.00504	0.0249	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00502	0.0064	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—AGT—metabolic syndrome X	0.00492	0.00627	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00491	0.00627	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—AGT—metabolic syndrome X	0.00481	0.00614	CbGpPWpGaD
Carboprost Tromethamine—Infection—Metformin—metabolic syndrome X	0.0048	0.0237	CcSEcCtD
Carboprost Tromethamine—Shock—Metformin—metabolic syndrome X	0.00476	0.0234	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Metformin—metabolic syndrome X	0.00467	0.023	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00441	0.0217	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—metabolic syndrome X	0.0044	0.00561	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Metformin—metabolic syndrome X	0.00434	0.0214	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Metformin—metabolic syndrome X	0.00431	0.0212	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—metabolic syndrome X	0.0043	0.00549	CbGpPWpGaD
Carboprost Tromethamine—Somnolence—Metformin—metabolic syndrome X	0.0043	0.0212	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00426	0.00543	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00417	0.00532	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GHRL—metabolic syndrome X	0.00404	0.00515	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GHRL—metabolic syndrome X	0.00395	0.00504	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00389	0.00496	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CNR1—metabolic syndrome X	0.00382	0.00488	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00381	0.00486	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CNR1—metabolic syndrome X	0.00374	0.00477	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Metformin—metabolic syndrome X	0.00347	0.0171	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Metformin—metabolic syndrome X	0.00331	0.0163	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00326	0.00415	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Metformin—metabolic syndrome X	0.0032	0.0158	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00319	0.00406	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00309	0.00394	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Metformin—metabolic syndrome X	0.00307	0.0152	CcSEcCtD
Carboprost Tromethamine—Rash—Metformin—metabolic syndrome X	0.00305	0.015	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Metformin—metabolic syndrome X	0.00305	0.015	CcSEcCtD
Carboprost Tromethamine—Headache—Metformin—metabolic syndrome X	0.00303	0.0149	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00302	0.00386	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCL5—metabolic syndrome X	0.00296	0.00378	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCL5—metabolic syndrome X	0.0029	0.0037	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Metformin—metabolic syndrome X	0.00287	0.0142	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00281	0.00358	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00275	0.0035	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00268	0.00342	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00262	0.00335	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—AGT—metabolic syndrome X	0.00248	0.00316	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—AGT—metabolic syndrome X	0.00243	0.0031	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00241	0.00307	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00236	0.00301	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00228	0.00291	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00223	0.00285	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00219	0.00279	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00216	0.00276	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00214	0.00273	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00212	0.0027	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GHRL—metabolic syndrome X	0.00207	0.00264	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CCL2—metabolic syndrome X	0.00204	0.0026	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GHRL—metabolic syndrome X	0.00203	0.00259	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CCL2—metabolic syndrome X	0.002	0.00255	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CNR1—metabolic syndrome X	0.00196	0.0025	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CNR1—metabolic syndrome X	0.00192	0.00245	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HDAC3—metabolic syndrome X	0.00185	0.00236	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HDAC3—metabolic syndrome X	0.00181	0.00231	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00167	0.00214	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00166	0.00211	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00164	0.00209	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00162	0.00207	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TRIB3—metabolic syndrome X	0.00162	0.00206	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RBP4—metabolic syndrome X	0.00162	0.00206	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.00161	0.00205	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TRIB3—metabolic syndrome X	0.00158	0.00202	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RBP4—metabolic syndrome X	0.00158	0.00202	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.00157	0.00201	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCL5—metabolic syndrome X	0.00152	0.00194	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00152	0.00193	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCL5—metabolic syndrome X	0.00149	0.0019	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00148	0.00189	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOC3—metabolic syndrome X	0.00143	0.00182	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AGT—metabolic syndrome X	0.0014	0.00179	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOC3—metabolic syndrome X	0.0014	0.00179	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AGT—metabolic syndrome X	0.00137	0.00175	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HTR2C—metabolic syndrome X	0.00129	0.00165	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AGT—metabolic syndrome X	0.00127	0.00162	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HTR2C—metabolic syndrome X	0.00126	0.00161	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CYBA—metabolic syndrome X	0.00125	0.0016	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AGT—metabolic syndrome X	0.00125	0.00159	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GHRL—metabolic syndrome X	0.00122	0.00156	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CYBA—metabolic syndrome X	0.00122	0.00156	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GHRL—metabolic syndrome X	0.0012	0.00153	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CNR1—metabolic syndrome X	0.00116	0.00148	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CNR1—metabolic syndrome X	0.00113	0.00145	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CCL2—metabolic syndrome X	0.00105	0.00134	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CCL2—metabolic syndrome X	0.00103	0.00131	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF2—metabolic syndrome X	0.000948	0.00121	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF2—metabolic syndrome X	0.000928	0.00118	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOB—metabolic syndrome X	0.00092	0.00117	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOB—metabolic syndrome X	0.000901	0.00115	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCL5—metabolic syndrome X	0.000898	0.00115	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000895	0.00114	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCL5—metabolic syndrome X	0.000879	0.00112	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LPL—metabolic syndrome X	0.000878	0.00112	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000876	0.00112	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LPL—metabolic syndrome X	0.00086	0.0011	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AGT—metabolic syndrome X	0.000752	0.000959	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LEP—metabolic syndrome X	0.000736	0.000939	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOE—metabolic syndrome X	0.000736	0.000939	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AGT—metabolic syndrome X	0.000736	0.000938	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—APOA1—metabolic syndrome X	0.000728	0.000928	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOE—metabolic syndrome X	0.000721	0.000919	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LEP—metabolic syndrome X	0.000721	0.000919	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—APOA1—metabolic syndrome X	0.000713	0.000909	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IRS1—metabolic syndrome X	0.000657	0.000838	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IRS1—metabolic syndrome X	0.000643	0.00082	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—INS—metabolic syndrome X	0.000629	0.000802	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CCL2—metabolic syndrome X	0.000619	0.000789	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—INS—metabolic syndrome X	0.000616	0.000785	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF1—metabolic syndrome X	0.000608	0.000776	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CCL2—metabolic syndrome X	0.000606	0.000773	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF1—metabolic syndrome X	0.000596	0.00076	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000578	0.000737	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000566	0.000721	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NOS3—metabolic syndrome X	0.000552	0.000704	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NOS3—metabolic syndrome X	0.00054	0.000689	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000473	0.000603	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL6—metabolic syndrome X	0.000465	0.000594	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000463	0.00059	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL6—metabolic syndrome X	0.000455	0.000581	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—metabolic syndrome X	0.000429	0.000548	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—metabolic syndrome X	0.00042	0.000536	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TGFB1—metabolic syndrome X	0.000365	0.000465	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TGFB1—metabolic syndrome X	0.000357	0.000455	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL6—metabolic syndrome X	0.000275	0.000351	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL6—metabolic syndrome X	0.000269	0.000343	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKT1—metabolic syndrome X	0.000254	0.000323	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKT1—metabolic syndrome X	0.000248	0.000317	CbGpPWpGaD
